Fertility preservation in women with CNS tumors

Expert Rev Anticancer Ther. 2017 May;17(5):439-445. doi: 10.1080/14737140.2017.1316195. Epub 2017 Apr 17.

Abstract

Fertility impairment due to treatments is a major concern for adolescents and young adult patients who survived cancer. Areas covered: Chemotherapy may determine a detrimental effect on ovary function, leading to infertility, and premature ovarian failure. Embryo and oocyte cryopreservation is a standard strategy for fertility preservation; other strategies, such as gonadal tissue cryopreservation and the use of gonadotropin - releasing hormone agonist, are still considered experimental. There are few data available regarding the effect of pregnancy on glioma, which indicates tumor progression during pregnancy in 33-45% of patients. Expert commentary: Glioma patients need to be advised about the risk of tumor progression during pregnancy, and about the possible, even if not proven, interaction between hormone stimulation and tumor growth.

Keywords: Glioma; fertility; pregnancy.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Central Nervous System Neoplasms / drug therapy*
  • Cryopreservation / methods
  • Female
  • Fertility Preservation / methods*
  • Glioma / drug therapy
  • Humans
  • Infertility, Female / chemically induced
  • Infertility, Female / prevention & control
  • Pregnancy
  • Pregnancy Complications, Neoplastic / pathology
  • Primary Ovarian Insufficiency / chemically induced
  • Survivors
  • Young Adult

Substances

  • Antineoplastic Agents